Seres Therapeutics CEO and key executive team

Seres Therapeutics's President, Chief Executive Officer & Director is Eric Shaff. Seres Therapeutics's key executives include Eric Shaff and 19 others.
Eric Shaff

Eric Shaff

President, Chief Executive Officer & Director
John Aunins

John Aunins

Executive Vice President of Bioprocess & Manufacturing and Chief Technology Officer
Kelly M. Brady

Kelly M. Brady

Vice President, Clinical Operations
Stephen Berenson

Stephen Berenson

Chairman
Gloria G. Cosgrove

Gloria G. Cosgrove

Vice President, Quality Systems
Grégory Behar

Grégory Behar

Director
Marcus Chapman

Marcus Chapman

SVP, Principal Financial Officer
Thomas J. Desrosier

Thomas J. Desrosier

Executive Vice President, Chief Legal Officer and Secretary
Dennis Ausiello

Dennis Ausiello

Director
Paul Biondi

Paul Biondi

Director
Matthew Henn

Matthew Henn

Executive Vice President, Chief Scientific Officer
Kurt Graves

Kurt Graves

Director
Barbara McGovern

Barbara McGovern

Vice President, Medical Affairs
Richard Kender

Richard Kender

Director
Meryl Zausner

Meryl Zausner

Director
Willard Dere

Willard Dere

Director
Jennifer R. Wortman

Jennifer R. Wortman

VP, Clinical Discovery and Research Technologies
Jim Weston

Jim Weston

Senior Vice President, Regulatory Affairs
Terri Young

Terri Young

EVP, Chief Commercial and Strategy Officer
Jeff York

Jeff York

Vice President, Human Resources
Last updated: